Determination of Non Alcoholic Fatty Liver Disease in Metabolic Syndrome Patients

Authors

  • Pinky Karam Department of Biochemistry, Sree Balaji Medical College and Hospital (Affiliated to Bharath Institute of Higher Education and Research), Chennai, Tamil Nadu, India.
  • B. Shanthi Department of Biochemistry, Sree Balaji Medical College and Hospital (Affiliated to Bharath Institute of Higher Education and Research), Chennai, Tamil Nadu, India.
  • Mary Chandrika Department of Biochemistry, Sree Balaji Medical College and Hospital (Affiliated to Bharath Institute of Higher Education and Research), Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.9734/bpi/caprd/v9/2472C

Keywords:

Metabolic syndrome, diabetes mellitus, cirrhosis, and hypertension

Abstract

The study's goal is to determine the association of nonalcoholic fatty liver disease in metabolic syndrome patients in order to determine the prevalence of nonalcoholic fatty liver disease in metabolic syndrome patients who have already been diagnosed in the South Indian population. Discover the relationship and general characteristics of nonalcoholic fatty liver disease in metabolic syndrome patients. To identify possible risk factors for steatohepatitis in patients with nonalcoholic fatty liver disease and metabolic syndrome, as well as risk categories for steatohepatitis in these patients. In nonalcoholic fatty liver cases, there is a rising incidence of all metabolic syndrome components, as well as alterations in biochemical markers.

Published

2022-02-23

How to Cite

Pinky Karam, B. Shanthi, & Mary Chandrika. (2022). Determination of Non Alcoholic Fatty Liver Disease in Metabolic Syndrome Patients. Current Aspects in Pharmaceutical Research and Development Vol. 9, 56–69. https://doi.org/10.9734/bpi/caprd/v9/2472C